2nd Oct 2018 07:00
2 October 2018
Cello Health plc
("Cello", the "Company", or the "Group")
Appointment of Executive Director
Further to the announcement of the Interim Results on 19 September 2018, Cello Health plc (AIM: CLL), the global healthcare-focused advisory Group, is pleased to announce that Julia Ralston has been appointed Executive Director of the Company with immediate effect, bringing the executive team to a total of four. Julia's presence on the Board will ensure appropriate levels of governance and control around Cello's expanding US business.
Julia is CEO of Cello Health in the US, having joined the Group as CEO of MedErgy in 2011 following its acquisition by Cello. Julia is responsible for Cello's strategic growth in the US and facilitating collaboration in the region across the Group's capabilities in consulting, insight, and communications.
Enquiries:
Cello Health plc | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Group Finance Director | |
Cenkos Securities plc | 020 7397 8900 |
Mark Connelly | |
Harry Hargreaves | |
Buchanan | 020 7466 5000 |
Mark Court | |
Jamie Hooper | |
Sophie Wills |
About Cello Health plc
Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.
Cello Health plc enables clients to commercialise and differentiate their assets and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit: https://cellohealthplc.com
Regulatory information
Full name (age) | Current directorships: | Previous directorships / partnerships (over the last five years): |
Julia Anne Ralston (61) | Cello Health Inc. Cello Health BioConsulting Inc. Cello Health Consulting Inc. Defined Health Inc. Worldwide Promedica Inc. Insight Research Group US Inc Cello Health Advantage Inc MedErgy HealthGroup Inc Cello Health Communications Inc MedErgy Scientific Inc SciFluent Communications Inc MedErgy Communications Inc | None |
As at today's date, Ms. Ralston holds 580,405 ordinary shares of 10p each in the capital of the Company.
There are no further disclosures to be made pursuant to Schedule Two, paragraph (g) of the AIM Rules for Companies in respect of the appointment of Ms. Ralston.
Related Shares:
CLL.L